Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Estradiol 9 Mcg/Estriol 0.5 mg Vaginal Suppository is a specially compounded medication. It is a solid dosage form that is inserted into the vagina, where it dissolves to release the medication. This formulation is primarily used for the treatment of conditions such as Atrophic Vaginitis, Menopausal Symptoms, Dyspareunia, Vulvovaginal Atrophy, and Genitourinary Syndrome of Menopause.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to offer a compounded formulation of Estradiol 9 Mcg/Estriol 0.5 mg Vaginal Suppository. This solid dosage form is designed to be inserted into the vagina, where it dissolves or melts to release the medication. The purpose of this method is to allow for local or systemic absorption of the medication, providing direct relief to the affected area.
This particular formulation is primarily used for the treatment of conditions such as atrophic vaginitis, menopausal symptoms, dyspareunia, vulvovaginal atrophy, and genitourinary syndrome of menopause. These conditions often result in uncomfortable symptoms like vaginal dryness, itching, burning, and pain during intercourse. The combination of estradiol and estriol in this formulation works to restore the natural balance of hormones in the body, providing relief from these symptoms.
The suppository form of delivery ensures that the medication is absorbed directly into the bloodstream.
If you have any questions about this compounded formulation of Estradiol 9 Mcg/Estriol 0.5 mg Vaginal Suppository, or if you would like to learn more about how it can help treat your condition, please do not hesitate to reach out to us at Bayview Pharmacy. Our team is dedicated to helping you find the best treatment option for your needs.
Estradiol 9 Mcg/Estriol 0.5 mg Vaginal Suppository is a compounded formulation designed for the treatment of atrophic vaginitis, menopausal symptoms, dyspareunia, vulvovaginal atrophy, and genitourinary syndrome of menopause. This medication is inserted into the vagina, where it dissolves to release the active ingredients for local absorption.
It is important to note that this formulation is contraindicated in patients with known hypersensitivity to estradiol or estriol. Additionally, estrogen therapy should not be used in women with a range of conditions including active thrombophlebitis or thromboembolic disorders, a history of endometrial cancer or endometrial hyperplasia, active or past history of breast cancer, active liver disease, known or suspected pregnancy, undiagnosed abnormal genital bleeding, known or suspected estrogen-dependent neoplasia, active deep vein thrombosis, pulmonary embolism, or history of these conditions, known or suspected hypercalcemia, and known or suspected hypersensitivity to any of the ingredients in the formulation.
Estrogen therapy may increase the risk of several health conditions including endometrial hyperplasia, endometrial cancer, breast cancer, thromboembolic disorders, stroke, coronary artery disease, hypercalcemia, liver disease, gallbladder disease, hypertension, hypertriglyceridemia, hypercholesterolemia, dementia, cataracts, endometriosis, ovarian cancer, uterine fibroids, deep vein thrombosis, and pulmonary embolism. Therefore, patients should be closely monitored for signs and symptoms of these conditions while undergoing treatment.
If you have any questions about the use of Estradiol 9 Mcg/Estriol 0.5 mg Vaginal Suppository for the treatment of atrophic vaginitis, menopausal symptoms, dyspareunia, vulvovaginal atrophy, and genitourinary syndrome of menopause, please do not hesitate to reach out for further information.
Estradiol 9 Mcg/Estriol 0.5 mg Vaginal Suppository is a specially compounded medication primarily used to alleviate a range of conditions associated with menopause. These conditions include atrophic vaginitis, menopausal symptoms, dyspareunia, vulvovaginal atrophy, and genitourinary syndrome of menopause. The suppository is designed to be inserted into the vagina, where it gradually dissolves to release the medication over a sustained period.
The medication contains two key active ingredients: estradiol and estriol. Estradiol works to reduce inflammation and restore the natural hormonal balance within the body, which can be disrupted during menopause.
The combination of estradiol and estriol in this formulation not only helps to manage the symptoms of menopause but also reduces the risk of developing complications associated with this stage of life. These complications can include osteoporosis and urinary tract infections. The suppository is typically used once daily for a period of up to 12 weeks. It can also be used in conjunction with other treatments, such as hormone replacement therapy, to provide comprehensive management of menopausal symptoms.
Patients should be aware that the use of this suppository may cause some initial irritation or a burning sensation upon insertion. If these symptoms persist, it is recommended to contact a healthcare provider for advice. This formulation is designed to provide targeted relief for menopausal symptoms, and any questions or concerns about its use or effects should be directed to a healthcare professional.
This is a compounded formulation of two hormones, Estradiol and Estriol. It is a solid dosage form that is inserted into the vagina, where it dissolves or melts to release the medication for local or systemic absorption.
Once inserted into the vagina, the suppository dissolves or melts, releasing the hormones Estradiol and Estriol. These hormones are then absorbed into the body, either locally or systemically, to help balance hormone levels.
You should insert the suppository into your vagina as directed by your healthcare provider. The suppository will dissolve or melt once inside, releasing the medication.
As with any medication, there can be side effects. These may include local irritation, itching, or burning. If you experience any severe or persistent side effects, you should contact your healthcare provider immediately.
You should always consult your healthcare provider before using any medication while pregnant or breastfeeding. They will be able to advise you on the potential risks and benefits.
It's important to tell your healthcare provider about all the medications you are currently taking, as there may be potential interactions. They will be able to advise you on whether it is safe to use this suppository with your other medications.
If you miss a dose, you should use it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
You should store this suppository in a cool, dry place, away from heat and light. Keep it out of reach of children and pets.
If you suspect an overdose, contact your healthcare provider or local poison control center immediately. Symptoms of an overdose may include severe nausea, vomiting, or vaginal bleeding.
It's best to consult your healthcare provider about using this suppository during your period. They will be able to provide you with the most accurate advice based on your specific situation.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert 1 unwrapped suppository
